Moreover, priming of AD‐MSCs with deferoxamine upregulated VEGF expression in a time and dose‐dependent manner, which was mediated by augmentation of HIF‐1 activity in AD‐MSCs, and increased their paracrine effect on endothelial cells (i.e., increase in migration).244. Here, VEGFA is linked to Alzheimer disease.